First Ai-Designed Drug Nears Final Trials Before Approval
In a milestone that marks a “before and after” in the history of medicine, the first drug entirely discovered and designed by artificial intelligence is preparing to enter Phase 3
In a milestone that marks a “before and after” in the history of medicine, the first drug entirely discovered and designed by artificial intelligence is preparing to enter Phase 3
In a move that signals a pivot from raw growth to fiscal discipline, OpenAI has reportedly doubled its “compute margins” for paid products, reaching a milestone of 70% as of
The race to power artificial intelligence has left terra firma behind. As the energy demands of generative AI threaten to overwhelm Earth’s power grids, tech giants and ambitious startups are